Parecer de pré-exame
#6.23
08/18/2026
RPI 2902
Application data
Number
112021010670Type
Filing
Publication
PCT
IB2019001292 Patent grant document available
We have the complete official document for this filing, as published by INPI.
Access the documentThe INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 08/18/2026. We update with every new RPI gazette, published weekly.
Applicants
FUSION PHARMACEUTICALS INC.
CA
Inventors
E. B. (pessoa física)
CA
J. V. (pessoa física)
CA
J. F. (pessoa física)
CA
M. H. (pessoa física)
CA
Priority claims
US
62/774,847 · 12/03/2018
Abstract
TERAPIA DE COMBINAÇÃO DE RADIOIMUNOCONJUGADO E INIBIDOR DE DANOS E REPARO DO DNA. Terapias de combinação compreendendo a administração de radioimunoconjugados e inibidores da resposta aos danos do DNA.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
08/18/2026
RPI 2902
#1.3
08/24/2021
RPI 2642
#1.1
06/08/2021
RPI 2631
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.